Publicaciones en las que colabora con ANTONIO SORLOZANO PUERTO (18)

2017

  1. Etiological and Resistance Profile of Bacteria Involved in Urinary Tract Infections in Young Children

    BioMed Research International, Vol. 2017

2015

  1. Different presence of chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and toxoplasma gondii in schizophrenia: Meta-analysis and analytical study

    Neuropsychiatric Disease and Treatment, Vol. 11, pp. 843-852

2014

  1. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study

    American Journal of Infection Control, Vol. 42, Núm. 10, pp. 1033-1038

  2. Sysmex UF-1000i performance for screening yeasts in urine

    APMIS, Vol. 122, Núm. 4, pp. 324-328

2012

  1. Infectious agents associated with schizophrenia: A meta-analysis

    Schizophrenia Research, Vol. 136, Núm. 1-3, pp. 128-136

2011

  1. Low impact of OmpC and OmpF on susceptibility to antibiotics in clinical isolates of Escherichia coli producers of extended-spectrum beta-lactamases

    Antibiotic Resistance: Causes and Risk Factors, Mechanisms and Alternatives (Nova Science Publishers, Inc.), pp. 261-270

  2. Performance to antibiotics in Staphylococcus aureus, Streptococcus agalactiae and Enterococcus spp.

    Antibiotic Resistance: Causes and Risk Factors, Mechanisms and Alternatives (Nova Science Publishers, Inc.), pp. 79-96

2010

  1. Relation between Epstein-Barr virus and multiple sclerosis: Analytic study of scientific production

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 29, Núm. 7, pp. 857-866

2007

  1. A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae

    Diagnostic Microbiology and Infectious Disease, Vol. 58, Núm. 4, pp. 487-489

  2. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli

    Journal of Basic Microbiology, Vol. 47, Núm. 5, pp. 413-416

  3. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-β-lactamase-producing Escherichia coli isolates

    Journal of Clinical Microbiology, Vol. 45, Núm. 8, pp. 2740-2742

  4. High presence of extended-spectrum β-lactamases and resistance to quinolones in clinical isolates of Escherichia coli

    Microbiological Research, Vol. 162, Núm. 4, pp. 347-354

2006

  1. Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum β-lactamase-producing Escherichia coli in Granada, Spain

    International Journal of Antimicrobial Agents, Vol. 28, Núm. 6, pp. 532-536

  2. Descripción de inmunógenos de Chlamydia pneumoniae reconocidos por el suero de sujetos con enfermedad arterial periférica

    Medicina Clinica, Vol. 126, Núm. 19, pp. 721-727

  3. In vitro activity of β-lactam and non-β-lactam antibiotics in extended-spectrum β-lactamase-producing clinical isolates of Escherichia coli

    Diagnostic Microbiology and Infectious Disease, Vol. 54, Núm. 2, pp. 135-139

  4. Meta-Analysis of Studies Analyzing the Relationship Between Bladder Cancer and Infection by Human Papillomavirus

    Journal of Urology, Vol. 176, Núm. 6, pp. 2474-2481

2005

  1. Relationship between peripheral arterial occlusive disease (PAOD) and chronic Chlamydophila (Chlamydia) pneumoniae infection. A meta-analysis

    Thrombosis and Haemostasis, Vol. 93, Núm. 6, pp. 1153-1160

2004

  1. Esclerosis múltiple, virus del herpes humano tipo 6 y Chlamydophila pneumoniae

    Revista Ecuatoriana de Neurologia, Vol. 13, Núm. 1-2, pp. 4-10